
UCLA CTSI and Caltech Host Webinar on FDA Strategy for Software, AI, and Medical Devices
Summary
The UCLA Clinical and Translational Science Institute (CTSI), in partnership with Caltech, hosted the webinar Great Idea, What’s Next? FDA Strategy for Software, AI and Medical Devices on October 14, bringing together researchers, clinicians, engineers, and innovators to learn about FDA requirements for emerging healthcare technologies. The program featured Marlene Berro, M.S., RAC, who provided practical guidance on regulatory strategy for software, AI, and medical devices, followed by a panel discussion with compliance and regulatory leaders from UCLA, Caltech, and Cedars-Sinai. The event drew 273 registrants and 135 live attendees from academic, healthcare, government, and industry organizations nationwide, highlighting strong interest in regulatory pathways for digital health and AI innovations and helping position CTSI for future educational programming in this area.
Article
The UCLA Clinical and Translational Science Institute (CTSI), in partnership with Caltech, hosted the webinar Great Idea, What's Next? FDA Strategy for Software, AI and Medical Devices on October 14, bringing together researchers, clinicians, engineers, entrepreneurs, and innovators to explore regulatory considerations for software, artificial intelligence (AI), and medical technologies.
The webinar featured Marlene Berro, MS, RAC, Director of FDA Affairs for the UCLA CTSI Office of Clinical Research, who provided practical guidance on navigating FDA requirements for software, AI, and medical devices. Through real-world examples, attendees learned how regulatory strategy can support the successful development and translation of healthcare technologies from concept to clinical impact.
Following the presentation, Arash Naeim, MD, PhD, CTSI Regulatory Knowledge and Support Program Co-Lead, moderated a panel discussion featuring regulatory and compliance leaders from UCLA, Caltech, and Cedars-Sinai. Panelists included:
Grace Fisher-Adams, PhD, JD, Associate Vice Provost for Research Policy and Compliance, Caltech
Keren Dunn, CIP, Executive Director, Office of Research Compliance and Quality Improvement, Cedars-Sinai
Marlene Berro, MS, RAC, Director of FDA Affairs, UCLA
Michael Roth, MD, Vice Chairman, Department of Medicine overseeing Research Compliance, UCLA
The event attracted 273 registrants and 135 live attendees representing academic institutions, healthcare organizations, government agencies, and industry partners. Attendees included representatives from UCLA, Cedars-Sinai, the Lundquist Institute, Caltech, Children's Hospital Los Angeles, Children's Mercy Kansas City, the University of Kansas Medical Center, the University of Pennsylvania, the University of Utah, the University of Illinois Chicago, and numerous additional organizations nationwide.
For more information or to schedule a regulatory consultation, visit the CTSI Office of Clinical Research's FDA Affairs program webpage.
https://ctsi.ucla.edu/articles/news/ctsi-and-caltech-host-webinar-on-fda-strategy-for



